Visteon Form 144: 1,200-share insider sale worth ~$132k disclosed

Rhea-AI Filing Summary

Visteon Corp. (VC) has filed a Form 144 indicating an insider’s intent to sell up to 1,200 common shares through Fidelity Brokerage on or after 01 Aug 2025. The proposed sale is valued at $131,829, based on the filing’s reference price, and represents roughly 0.004% of the 27.28 million shares outstanding. The shares originated from restricted-stock vesting on 15 Feb 2023 and were received as compensation; no shares have been sold by this filer in the prior three months.

• No material adverse information is claimed by the seller, as affirmed in the signature section.
• The notice does not amend earnings guidance, announce operational events, or affect capital structure; its sole purpose is to comply with Rule 144 disclosure for a routine, small-scale disposition.

Given the limited size relative to float, market impact should be minimal, though investors often monitor insider activity as a sentiment indicator.

Positive

• Sale represents only ~0.004% of shares outstanding, implying minimal dilution or price impact.
• Filer attests to no undisclosed adverse information, supporting governance transparency.

Negative

• Insider selling—even small—can be viewed as a cautious sentiment signal for some investors.

Insights

Securities Analyst

TL;DR: Minor insider sale; negligible dilution risk; neutral signal.

The proposed 1,200-share sale equals ~0.004% of VC’s shares outstanding and just $132k in value. Such a small trade is unlikely to pressure liquidity or signal strategic shifts. Because shares were acquired via compensation, the transaction appears to be routine diversification rather than a confidence statement. I view the filing as non-material; insider selling trends would merit scrutiny only if volumes or seniority escalate.

Corporate Governance Expert

TL;DR: Routine Rule 144 compliance; corporate governance intact.

Form 144 confirms adherence to SEC disclosure rules prior to public-market sales of restricted stock. The signer attests to possessing no undisclosed adverse information, reducing information-asymmetry risk. No aggregate sales in the last three months further implies limited pattern selling. From a governance standpoint, the filing demonstrates procedural compliance and raises no red flags.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	1200	131829.13	27276339	08/01/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/15/2023	Restricted Stock Vesting	Issuer			1200	02/15/2023	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did Visteon (VC) disclose in its Form 144 filing?

VC disclosed an insider’s plan to sell 1,200 common shares worth approximately $131,829 on or after 01 Aug 2025.

How significant is the 1,200-share sale relative to Visteon’s float?

The proposed sale equals about 0.004% of the 27.28 million shares outstanding, a very small fraction.

When were the shares to be sold originally acquired?

They vested as restricted stock compensation on 15 Feb 2023.

Has this insider sold Visteon shares in the past three months?

No. The filing states “Nothing to Report” for prior three-month sales.

Does the Form 144 indicate any operational or financial changes at Visteon?

No. It is purely a notice of proposed share sale and contains no earnings or operational updates.